Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Heterocyclic-substituted pyrimidine derivative exhibiting cancer cell growth inhibitory effect, and pharmaceutical composition containing same

US Patent 12421221 · Granted Sep 23, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →